Login / Signup

Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States.

Wanjun BaiXue SunBo QiuCaihui GuoHaojing SongYiting HuXueyuan ZhangPeihua YinXiaoru WangZhanjun Dong
Published in: Drug design, development and therapy (2024)
chinaDrugtrials.org.cn, identifier CTR20191056 (July 30, 2019); chictr.org.cn, identifier ChiCTR2300076806 (October 19, 2023).
Keyphrases
  • blood glucose
  • lymph node metastasis
  • insulin resistance
  • squamous cell carcinoma
  • weight loss